Access the comprehensive database of gene therapy company domains. From viral vector developers to gene editing pioneers, discover verified websites of genetic medicine organizations transforming hereditary disease treatment.
Navigate the genetic medicine landscape with comprehensive data on gene therapy developers and innovators.
Gene therapy represents one of the most transformative frontiers in medicine, offering potential cures for previously untreatable genetic disorders. Our database provides access to AAV vector developers, lentiviral platform companies, and in vivo gene delivery specialists.
Whether you're tracking FDA-approved gene therapies, analyzing clinical trial progress, or identifying licensing opportunities, our database delivers intelligence on companies developing treatments for rare diseases, inherited conditions, and beyond.
"The global gene therapy market is projected to exceed $35 billion by 2030, driven by breakthrough approvals and expanded manufacturing capacity." Our Cell Therapy Developers list offers complementary insights.
-- Gene Therapy Market Analysis, 2024Comprehensive coverage of the genetic medicine sector. Expand your research by viewing the CRISPR/Gene Editing section.
Adeno-associated virus platforms
Ex vivo gene transfer. Professionals in this field often consult our Biologics Developers data.
Inherited retinal diseases
Neurological disorders. Discover more opportunities in the Regenerative Medicine category.
Heart failure treatments
Orphan genetic conditions
Get instant access to 1,800+ gene therapy company domains with comprehensive enrichment data. You may also be interested in our Clinical Stage Biotech dataset.
View Pricing Plans Back to Biotech & Biomedical